Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 826.00
-10.00 (-1.20%)
Sep 16, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.27 billion as of September 15, 2026. Its market cap has decreased by -46.10% in one year.
Market Cap
4.27B
Enterprise Value
3.73B
Revenue
4.69B
Ranking
n/a
PE Ratio
33.39
Stock Price
826.00
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.27B, a decrease of -64.05%. That is a compound annual growth rate of -34.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 4.27B | -43.85% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noile-Immune Biotech | 6.03B |
| PRISM BioLab Co.,LTD | 5.99B |
| Soiken Holdings | 5.57B |
| TMS Co., Ltd. | 5.39B |
| Chordia Therapeutics | 5.33B |
| D. Western Therapeutics Institute | 5.01B |
| Ribomic | 4.52B |
| Transgenic Group | 4.33B |